13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001425738
申报总市值
US$14.9亿
US$14.9亿
77 檔
50.7%
Q1 2024 季度申报显示，Redmile Group, LLC 披露的美股组合总市值为 US$14.9亿，涵盖 77 个不同之权益投资仓位。
在 Q1 2024，Redmile Group, LLC 操作展现出积极扩展与加仓意向。本季共新建仓 15 个新仓位，并对 13 个既有持股进行加仓（合计增持 28 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Redmile Group, LLC 的前 5 大核心持股（包含 KRYS, AM6, IMNM 等）合计占整体申报市值的 50.7%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 9.85% | +4.25% | -12.98% | |
| 2 | AM6 | Amicus Therapeutics Inc | 股票-其他 | 5.73% | — | -10.59% | |
| 3 | IMNM | Immunome Inc | 股票-其他 | 4.43% | -1.06% | +26.04% | |
| 4 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 4.18% | -13.59% | +0.27% | |
| 5 | FATE | Fate Therapeutics Inc | 股票-其他 | 3.55% | +1.31% | — | |
| 6 | RGNX | Regenxbio Inc | 股票-其他 | 3.52% | +1.09% | +21.03% | |
| 7 | DCPHEUR | Deciphera Pharmaceuticals In | 股票-其他 | 3.06% | — | +10.31% | |
| 8 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 2.56% | — | -4.93% | |
| 9 | ✓ | Adc Therapeutics SA | 股票-其他 | 2.52% | -3.01% | -0.39% | |
| 10 | STOK | Stoke Therapeutics Inc | 股票-其他 | 2.51% | -0.31% | +93.22% | |
| 11 | AUGX | Augmedix Inc | 股票-其他 | 2.46% | — | — | |
| 12 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 2.42% | -1.30% | +37.66% | |
| 13 | BHVN | Biohaven Ltd. | 股票-其他 | 2.33% | — | -19.46% | |
| 14 | BEAM | Beam Therapeutics Inc | 股票-其他 | 2.28% | +0.73% | +31.46% | |
| 15 | ZYME | Zymeworks Inc | 股票-其他 | 2.15% | +0.04% | -3.96% | |
| 16 | LIVN | LivaNova PLC | 股票-其他 | 2.13% | +0.05% | -8.73% | |
| 17 | STTK | Shattuck Labs Inc | 股票-其他 | 1.84% | +0.85% | -0.08% | |
| 18 | ALXO | Alx Oncology Holdings Inc | 股票-其他 | 1.77% | -0.03% | +18.23% | |
| 19 | NGNE | Neurogene Inc | 股票-其他 | 1.75% | +1.03% | -1.23% | |
| 20 | AKRO | Akero Therapeutics Inc | 股票-其他 | 1.72% | — | +67.53% | |
| 21 | ABSI | Absci CORP | 股票-其他 | 1.72% | +3.60% | +2.77% | |
| 22 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 1.69% | — | +14.85% | |
| 23 | SLN | Silence Therapeutics Plc-adr | 股票-其他 | 1.61% | +0.84% | — | |
| 24 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 1.49% | +0.45% | -1.41% | |
| 25 | FDMT | 4d Molecular Therapeutics In | 股票-其他 | 1.48% | — | — | |
| 26 | ANNX | Annexon Inc | 股票-其他 | 1.45% | -0.79% | — | |
| 27 | BSX | Boston Scientific CORP | 股票-医疗保健 | 1.41% | — | -19.08% | |
| 28 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.38% | +0.53% | -9.80% | |
| 29 | KROS | Keros Therapeutics Inc | 股票-其他 | 1.34% | — | — | |
| 30 | CTLTEUR | Catalent Inc | 股票-其他 | 1.31% | — | -42.53% | |
| 31 | IMVT | Immunovant Inc | 股票-其他 | 1.15% | — | -0.76% | |
| 32 | REPL | Replimune Group Inc | 股票-其他 | 1.12% | — | -3.50% | |
| 33 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.09% | — | -1.18% | |
| 34 | 1K0 | Igm Biosciences Inc | 股票-其他 | 1.09% | — | +3.40% | |
| 35 | ALGN | Align Technology Inc | 股票-医疗保健 | 1.05% | — | +74.22% | |
| 36 | COGT | Cogent Biosciences Inc | 股票-其他 | 0.98% | -0.44% | +35.98% | |
| 37 | ETNBGBP | 89bio Inc | 股票-其他 | 0.97% | — | +14.99% | |
| 38 | CI | THE Cigna Group | 股票-医疗保健 | 0.87% | — | — | |
| 39 | EVH | Evolent Health Inc - A | 股票-其他 | 0.82% | — | -18.71% | |
| 40 | ✓ | Verve Therapeutics Inc | 股票-其他 | 0.78% | — | -6.64% | |
| 41 | TRDA | Entrada Therapeutics Inc | 股票-其他 | 0.67% | — | — | |
| 42 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 0.64% | — | -20.59% | |
| 43 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.59% | — | +35.29% | |
| 44 | ARDX | Ardelyx Inc | 股票-其他 | 0.59% | -0.07% | — | |
| 45 | BOLD | Boundless Bio Inc | 股票-其他 | 0.58% | — | — | |
| 46 | SYK | Stryker CORP | 股票-医疗保健 | 0.57% | — | -18.62% | |
| 47 | 2JQ | Gritstone Bio Inc | 股票-其他 | 0.54% | — | -2.00% | |
| 48 | PRME | Prime Medicine Inc | 股票-其他 | 0.53% | -0.03% | +56.63% | |
| 49 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 0.46% | — | — | |
| 50 | PGNY | Progyny Inc | 股票-其他 | 0.45% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | IMNM | Immunome Inc | +3% | +26.04% | 加仓 |
| 2 | KRYS | Krystal Biotech Inc | +2.2% | -12.98% | 减仓 |
| 3 | STOK | Stoke Therapeutics Inc | +2% | +93.22% | 加仓 |
| 4 | FATE | Fate Therapeutics Inc | +1.8% | — | 不变 |
| 5 | SLN | Silence Therapeutics Plc-adr | +1.6% | NEW | 新建仓 |
| 6 | ✓ | Adc Therapeutics SA | +1.6% | -0.39% | 减仓 |
| 7 | FDMT | 4d Molecular Therapeutics In | +1.5% | NEW | 新建仓 |
| 8 | KROS | Keros Therapeutics Inc | +1.3% | NEW | 新建仓 |
| 9 | NRIX | Nurix Therapeutics Inc | +1.2% | +37.66% | 加仓 |
| 10 | RGNX | Regenxbio Inc | +1.1% | +21.03% | 加仓 |
| 11 | NGNE | Neurogene Inc | +1.1% | -1.23% | 减仓 |
| 12 | KYMR | Kymera Therapeutics Inc | +0.9% | -4.93% | 减仓 |
| 13 | BEAM | Beam Therapeutics Inc | +0.9% | +31.46% | 加仓 |
| 14 | CI | THE Cigna Group | +0.9% | NEW | 新建仓 |
| 15 | AKRO | Akero Therapeutics Inc | +0.8% | +67.53% | 加仓 |
| 16 | ARDX | Ardelyx Inc | +0.6% | NEW | 新建仓 |
| 17 | BOLD | Boundless Bio Inc | +0.6% | NEW | 新建仓 |
| 18 | ALGN | Align Technology Inc | +0.6% | +74.22% | 加仓 |
| 19 | ANNX | Annexon Inc | +0.6% | — | 不变 |
| 20 | ABSI | Absci CORP | +0.5% | +2.77% | 加仓 |
| 21 | ICLR | ICON Public Limited Company | +0.5% | NEW | 新建仓 |
| 22 | PGNY | Progyny Inc | +0.5% | NEW | 新建仓 |
| 23 | VTYXUSD | Ventyx Biosciences Inc | +0.4% | +944.45% | 加仓 |
| 24 | CYTK | Cytokinetics Inc | +0.4% | NEW | 新建仓 |
| 25 | DGX | Quest Diagnostics Inc | +0.4% | NEW | 新建仓 |
| 26 | MCK | Mckesson CORP | +0.4% | NEW | 新建仓 |
| 27 | STTK | Shattuck Labs Inc | +0.4% | -0.08% | 减仓 |
| 28 | ELAN | Elanco Animal Health Inc | +0.4% | NEW | 新建仓 |
| 29 | 2655787D | Blueprint Medicines CORP | +0.4% | NEW | 新建仓 |
| 30 | COGT | Cogent Biosciences Inc | +0.4% | +35.98% | 加仓 |
| 31 | APLSUSD | Apellis Pharmaceuticals Inc | +0.3% | NEW | 新建仓 |
| 32 | IDYA | Ideaya Biosciences Inc | +0.3% | -1.41% | 减仓 |
| 33 | DCPHEUR | Deciphera Pharmaceuticals In | +0.3% | +10.31% | 加仓 |
| 34 | NUVB | Nuvation Bio Inc | +0.2% | — | 不变 |
| 35 | ✓ | Establishment Labs Holdings In | +0.2% | NEW | 新建仓 |
| 36 | SRRK | Scholar Rock Holding CORP | -0.1% | +0.27% | 加仓 |
| 37 | ALXO | Alx Oncology Holdings Inc | -0.2% | +18.23% | 加仓 |
| 38 | ALLKGUSD | Allakos Inc | -0.2% | -5.98% | 减仓 |
| 39 | RPTX | Repare Therapeutics Inc | -0.2% | -6.16% | 减仓 |
| 40 | ISRG | Intuitive Surgical Inc | -0.2% | -45.55% | 减仓 |
| 41 | IMVT | Immunovant Inc | -0.3% | -0.76% | 减仓 |
| 42 | CTLTEUR | Catalent Inc | -0.5% | -42.53% | 减仓 |
| 43 | PEN | Penumbra Inc | -0.5% | -53.16% | 减仓 |
| 44 | CRL | Charles River Laboratories | -0.7% | EXIT | 清仓 |
| 45 | CABA | Cabaletta Bio Inc | -0.8% | -67.78% | 减仓 |
| 46 | AUGX | Augmedix Inc | -1% | — | 不变 |
| 47 | AM6 | Amicus Therapeutics Inc | -1.8% | -10.59% | 减仓 |
| 48 | SPY | Ss Spdr S&p 500 ETF Trust-us | -2.4% | EXIT | 清仓 |
| 49 | ✓ | Rayzebio Inc | -4.1% | EXIT | 清仓 |
| 50 | IMGNEUR | Immunogen Inc | -17.4% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Redmile Group, LLC 在 Q1 2024 季度的美股持仓总市值约为 US$14.9亿，共申报了 77 个公开持股仓位。
在 Q1 2024 季度，Redmile Group, LLC 按市值排列的前三大核心持股分别为：KRYS (9.8%)、AM6 (5.7%)、IMNM (4.4%)。其中最大持股仓位 KRYS 占据整体投资组合约 9.8% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
SLN
市值: US$4379.8万
本季最大获利了结 / 清仓标的
IMGNEUR
前期市值: US$4.9亿
在 Q1 2024 季度中，Redmile Group, LLC 共进行了 46 项持仓异动，包含新建仓 15 个仓位、加仓 13 个仓位、减仓 14 个仓位以及清仓 4 个仓位。 其中最大新建仓标的为 SLN。 本季清仓仓位包含 IMGNEUR。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。